Zydus, MSN Laboratories Launch First Generic Adempas in US

Zydus Lifesciences Limited, in partnership with MSN Laboratories Private Limited, has launched the first generic version of Adempas (Riociguat tablets) in the US market. The launch includes Riociguat tablets in all five strengths: 0.5 mg, 1 mg, 1.5 mg, 2 mg and 2.5 mg.